Singapore: Biofourmis raises $5m Series A from NSI Ventures, Aviva Ventures

Singapore-based health analytics platform Biofourmis has closed a $5-million Series A round from NSI Ventures and Aviva Ventures, in addition to securing a partnership with US-based Mayo Clinic.

NSI Ventures, a unit of Singapore-based private equity (PE) firm Northstar Group, is currently investing out of its second fund. It is understood to have raised about $60 million for the vehicle already. Aviva Ventures is the venture capital (VC) arm of British insurance firm Aviva.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter